Back to Search Start Over

Phase II study of erlotinib in advanced non-small-cell lung cancer after failure of gefitinib.

Authors :
Cho BC
Im CK
Park MS
Kim SK
Chang J
Park JP
Choi HJ
Kim YJ
Shin SJ
Sohn JH
Kim H
Kim JH
Source :
Journal of Clinical Oncology; 6/20/2007, Vol. 25 Issue 18, p2528-2533, 6p
Publication Year :
2007

Details

Language :
English
ISSN :
0732183X
Volume :
25
Issue :
18
Database :
Supplemental Index
Journal :
Journal of Clinical Oncology
Publication Type :
Academic Journal
Accession number :
105953865